Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA HCG18 Promotes Clear Cell Renal Cell Carcinoma Progression by Targeting miR-152-3p to Upregulate RAB14
Yang Yu, Pengfeng Gong, Dongwei Yao, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 2287-2294
Open Access | Times Cited: 22

Showing 22 citing articles:

LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis
Xiaohui Pan, Jin Guo, Canjun Liu, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 37
A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment
Qi Zhang, Hao Ren, Luqi Ge, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b
Fan Zhang, Baihua Luo, Qihui Wu, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 28
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
Zhongbao Zhou, Zhenpeng Yang, Yuanshan Cui, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 27
The regulatory role of LncRNA HCG18 in various cancers
Zhuoying Du, Bei Wang, Fangshun Tan, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 4, pp. 351-360
Closed Access | Times Cited: 10
LncRNA HCG18 promotes prostate cancer progression by regulating miR-512-3p/HK-2 axis
Yaru Zhu, Zhijing Wang, Haopeng Li, et al.
Asian journal of urology (2024) Vol. 11, Iss. 4, pp. 575-585
Open Access | Times Cited: 3
Effects of total glucosides of paeony on acute renal injury following ischemia–reperfusion via the lncRNA HCG18/miR-16-5p/Bcl-2 axis
Wei Zhao, Yuan Zhang, Mingzhu Zhang, et al.
Immunobiology (2022) Vol. 227, Iss. 2, pp. 152179-152179
Closed Access | Times Cited: 13
LncRNA HCG18 affects diabetic cardiomyopathy and its association with miR-9-5p/IGF2R axis
Yuhui Luo, Yi Jiang, Tingting Zhong, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24604-e24604
Open Access | Times Cited: 2
The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets
Xin Li, Biao Qian, Xu Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
LINC01232 serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma
Qingling Liu, Chengbin Lei
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 2153-2164
Open Access | Times Cited: 14
LncRNA HCG18 facilitates melanoma progression by modulating miR-324-5p/CDK16 axis.
Chengwei Zhang, Haitao Lv, Fengling Zhang, et al.
PubMed (2022) Vol. 14, Iss. 2, pp. 1246-1257
Closed Access | Times Cited: 6
LncRNA HCG18 promotes M2 macrophage polarization to accelerate cetuximab resistance in colorectal cancer through regulating miR-365a-3p/FOXO1/CSF-1 axis
Cao Gao, Wenwei Hu, Jiemin Zhao, et al.
Pathology - Research and Practice (2022) Vol. 240, pp. 154227-154227
Closed Access | Times Cited: 6
Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma
Fang Tong, Lifa Xu, Sheng Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
The role of long non-coding RNA HCG18 in cancer
Zhiqiang Wang, Rui Ran, Zhang Shun-bai, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 3, pp. 611-619
Closed Access | Times Cited: 5
LUNCRW: Prediction of potential lncRNA-disease associations based on unbalanced neighborhood constraint random walk
Guobo Xie, Shigang Liu, Guosheng Gu, et al.
Analytical Biochemistry (2023) Vol. 679, pp. 115297-115297
Closed Access | Times Cited: 2
The role of lncRNA HCG18 in human diseases
Feng Long, Xuan Zhou, Jinhua Zhang, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access
LncRNA HCG18 affects aortic dissection through the miR-103a-3p/HMGA2 axis by modulating proliferation and apoptosis of vascular smoothing muscle cells
ZhiHong Yang, Yuansheng Cui, S D Xu, et al.
Clinics (2024) Vol. 79, pp. 100400-100400
Open Access
Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network
Zhiliang Xiao, Menglei Zhang, Zhenduo Shi, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-19
Open Access
LncRNA MAGI2-AS3 inhibited tumour progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma
Riwei Yang, Zude Chen, Shan Ao, et al.
Research Square (Research Square) (2023)
Open Access
Expression and diagnostic value of lncRNA HCG18 in gestational diabetes mellitus
Lin Chen, Jie Jiang, Yong Tian
Ginekologia Polska (2023)
Open Access
LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma
Riwei Yang, Zude Chen, Shan Ao, et al.
Cellular Signalling (2023) Vol. 113, pp. 110954-110954
Closed Access
LncRNA HCG18 promotes Prostate Cancer progression by regulating miR-512-3p/HK-2 axis
Yaru Zhu, Zhijing Wang, Haopeng Li, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top